First quarterly positive adjusted EBITDA of $0.2M in Q4 2019
27% increase in Q4 2019 net cannabis revenue over the previous quarter1,748% increase in FY 2019 net cannabis revenue over the previous yearGross margin on cannabis net revenue of 80% in Q4 2019Q4 2019 SG&A expenses of $4.3 million, a decrease of 11% over previous quarter$41.2M cash and cash equivalents at December 31, 2019Fourth consecutive quarter reporting record revenueTORONTO, March 18, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), is pleased to report its financial results for the 2019 fourth quarter (“Q4 2019”) and fiscal year (“FY 2019”).Management Commentary
Bay Street News